Načítá se...
BCLC-B hepatocellular carcinoma treatment or when should the systemic therapy be started
Choice of the optimal therapy for BCLC-B hepatocellular carcinoma (HCC) is a significant clinical problem. Transarterial chemoembolisation (TACE) is considered to be the method of choice as this approach is reported to produce a direct effect and to have a significant survival rate. However, TACE is...
Uloženo v:
| Hlavní autoři: | , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Russo |
| Vydáno: |
Remedium Group LLC
2018-07-01
|
| Edice: | Медицинский совет |
| Témata: | |
| On-line přístup: | https://www.med-sovet.pro/jour/article/view/2529 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|